Home » Stocks » Amarin

Amarin Corporation Plc (AMRN)

Stock Price: $6.77 USD 0.29 (4.48%)
Updated Aug 3, 2020 4:00 PM EDT - Market closed
After-hours: $6.82 +0.05 (0.74%) Aug 3, 6:42 PM

Stock Price Chart

Key Info

Market Cap 2.61B
Revenue (ttm) 511.47M
Net Income (ttm) -18.77M
Shares Out 385.49M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 3, 2020
Last Price $6.77
Previous Close $6.48
Change ($) 0.29
Change (%) 4.48%
Day's Open 6.48
Day's Range 6.47 - 6.80
Day's Volume 6,739,677
52-Week Range 3.95 - 26.12

More Stats

Market Cap 2.61B
Enterprise Value 2.11B
Earnings Date (est) Aug 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 385.49M
Float 347.03M
EPS (basic) -0.06
EPS (diluted) -0.07
FCF / Share 0.08
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 1.15%
Payout Ratio n/a
Shares Short 32.31M
Short Ratio 5.94
Short % of Float n/a
Beta 2.73
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 86.64
PS Ratio 5.10
PB Ratio 4.51
Revenue 511.47M
Operating Income -25.57M
Net Income -18.77M
Free Cash Flow 30.13M
Net Cash 499.79M
Net Cash / Share 1.30
Gross Margin 65.25%
Operating Margin -5.00%
Profit Margin -3.70%
FCF Margin 5.89%
ROA -2.46%
ROE -5.17%
ROIC -16.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (11)

Buy 7
Overweight 0
Hold 4
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(148.15% upside)
Current: $6.77
Target: 16.80
*Average 12-month price target from 10 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth87.49%26.56%39.22%59.11%50.84%105.69%----
Gross Profit33417513695.7253.8833.7214.44---
Operating Income-24.28-108-45.56-65.63-98.22-95.96-182-117-44.16-45.10
Net Income-22.65-116-67.87-86.35-115-56.36-166-179-69.13-250
Shares Outstanding343297271212181174161144130100
Earnings Per Share-0.07-0.39-0.25-0.41-0.83-0.36-1.28-1.24-0.53-2.49
Operating Cash Flow-9.37-94.70-32.84-71.82-84.02-74.61-190-122-39.44-33.87
Capital Expenditures-2.48-0.06-0.01-0.02-0.03--0.01-12.69-0.40-0.02
Free Cash Flow-11.84-94.76-32.85-71.84-84.05-74.61-190-135-39.84-33.89
Cash & Equivalents64825174.2498.8510812019326011731.44
Total Debt59.5780.35123116251234261234-0.09
Net Cash / Debt589170-48.42-17.60-144-114-68.5926.2611731.35
Book Value608152-65.10-9.06-128-88.45-33.86-4.00-5.96-202
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Amarin Corporation Plc
Country Ireland
Employees 965
CEO John F. Thero

Stock Information

Ticker Symbol AMRN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AMRN
IPO Date April 1, 1993


Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.